Life Sciences

Enabling Value Based Care
Home Life Sciences

A fundamental shift in health benchmarks towards value-based care and patient-centricity has disrupted the Life Sciences industry. These increased expectations have eventually resulted in innovator companies reevaluating development programs, innovate business models, adopt new technologies, redefine reimbursement strategy and clinical pipeline approach. Accommodating these disruptions is challenging and that can be achieved through improved R&D productivity, accelerated R&D and product development, and building partnerships throughout the value chain.

FutureBridge enables these aspirations of Life Sciences innovators by providing actionable techno-commercial insights derived from its customized intelligence programs that are backed by scientific proof, sentiments of key opinion leaders, and voice of the industry.

Oncology Solutions

Our customized oncology consulting services integrate in-depth
industry knowledge, relevant-analytics platforms, and PoVs
from leading external experts to offer efficient solutions
to pharmaceutical and biotech companies in the domains
of therapeutics and diagnostics.

Oncology Solutions

Our customized oncology consulting services integrate in-depth
industry knowledge, relevant-analytics platforms, and PoVs
from leading external experts to offer efficient solutions
to pharmaceutical and biotech companies in the domains
of therapeutics and diagnostics.

Life Sciences

Innovations in Navigation and Imaging Technologies – Shaping the Future of Surgery
Non-invasive (NI) and minimally invasive (MI) surgical procedures are accomplished through sophisticated and flexible small tubes, tiny cameras, and surgical instruments, with less damage to the body than with open surgery. Medical fraternities have joined hands with...

Life Sciences

Cell Therapies in Solid Tumors: A bright future or a long shot
Surmounting all the challenges, 1st cell therapy approval in solid tumors is anticipated by 2022. The spectacular success of cell therapies observed in heme tumors is not yet realized in solid tumors, however, stepped-up efforts to defeat unyielding tumor...

Challenges and Innovations in Drug-delivery Systems

Life Sciences

Overview Table of Contents Research Methodology The evolution and upgradation in the drug delivery strategies have greatly aided in the...

Innovation and Trends in Ophthalmic Diagnostic Devices

Life Sciences

Overview Table of Contents Research Methodology The ophthalmic technology is continually advancing in all areas of formulations, surgical...

Research Report | Antibody Drug Conjugates: ASCO 2022 & Beyond

Life Sciences

FutureBridge Oncology consulting team identified 3 transformative themes at the ASCO 2022 that will impact the future.  Antibody Drug...

Diabetes: Scope of Diabetes Management

Life Sciences

Diabetic patients require daily blood glucose checks and insulin injections to maintain their blood glucose levels within the target...

Strategic Growth Fields

A convergence of industry transformations and exponential technologies creates a pool of opportunities

Paradigm Shift in
R&D

  • Shared risks & costs
  • Virtual clinical trials & remote R&D
  • Portfolio optimization & LCM
  • Naturals & Alternatives

Personalization &
Precision

  • Theragnostics
  • Gene & cell therapy
  • Targeted drug delivery
  • Minimally invasive surgery (MIS)

Preventive Care & Predictive Diagnostics

  • Prophylactic care & vaccination
  • Early screening & rapid diagnosis
  • Real-time monitoring & treatment
  • Therapeutic nutrition

Evolving
Ecosystem

  • Value-based care
  • Home care
  • Patient Centricity & patient partnership
  • Wellness & self-care
Exponential Digital Technologies
  • Sustainability 85% 85%
  • Digitalization 94% 94%
  • Business Model Innovation 87% 87%
  • Synthetic Biology 92% 92%
  • Big Data & Clinical Algorithms 85% 85%

Our Solutions

Our solutions combine a unique blend of research, consulting, and hyper-intelligence industry & technology platforms for deep insights
With our techno-commercial acumen, we unearth growth opportunities, connect technologies with markets and deliver business impact

test

Future of Life Sciences

icon Therapies
icon Technology Platforms
icon Markets
icon Disease Patterns
icon Competition
icon Regulation & Reimbursement

Future of Life Sciences

icon Therapies
icon Technology Platforms
icon Markets
icon Disease Patterns
icon Competition
icon Regulation & Reimbursement
Foresight & Weak Signals
Key Industry Trends & Exponential Technologies
Technology Landscape & Deep Dive
Markets & Regulations Assessment
Technology Roadmaps & Horizon Planning
Business Disruption Monitoring & Opportunity Radar
Solutions Scouting & Benchmarking
Technology, Market & Business Model Evaluation
Innovation Pipeline Development
Partner & Supplier Identification & Assessment
Business Continuity: Key Data, Competitive Positioning, and Customer Analysis
Partner/Supplier Collaboration & M&A Support
Technology Adoption
Technology Commercialization
Company / Technology Benchmarking & Due Diligence
Technology Implementation Ecosystems

The Business Functions for Whom We Create Value

Insights
Strategize
Implement Disruption
How can I be faster and more dynamic in product development?
How are gene therapy related devices are evolving?
Is it feasible to adapt MoAs from other therapy areas to our focus areas?
What are different Digital technologies for active patient engagement?
What are the unmet needs in existing product portfolio?
How can we prioritize the ongoing developments to be ahead in the competition in the Oncology?
What are the new regulations related to digital therapeutics?
What are new routes of drug delivery under clinical trials?
What are the technologies available to improve & measure efficacy of naturals for treatment?
What are future scenarios for my industry?
Early Signals
Landscape –Technology, Competition, Disease, Indications, Systems
Growth Opportunity identification – Drugs, Devices, Platforms, Markets, Products, Partnerships
Policy & Regulations
Success Case Studies & Evolving Business Models
Collaboration and M&A Support

Life science

Therapies

Technology Platforms

Markets

Disease Patterns

Competition

Regulation & Reimbursement

Short Term
Medium Term
Long Term

The Business Functions for Whom We Create Value

Diverse technological advancements will define the future of connected mobility

The Business Functions For Whom We Create Value

Diverse technological advancements will define future of connected mobility

  • Insights
  • Strategize
  • Implement Disruption
  • How can I be faster and more dynamic in product development?
  • How are gene therapy related devices are evolving?
  • Is it feasible to adapt MoAs from other therapy areas to our focus areas?
  • What are different Digital technologies for active patient engagement?
  • What are the unmet needs in existing product portfolio?
  • How can we prioritize the ongoing developments to be ahead in the competition in the Oncology?
  • What are new routes of drug delivery under clinical trials?
  • What are the technologies available to improve & measure efficacy of naturals for treatment?
  • What are future scenarios for my industry?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Early Signals
  • Landscape –Technology, Competition, Disease, Indications, Systems
  • Growth Opportunity identification – Drugs, Devices, Platforms, Markets, Products, Partnerships
  • Policy & Regulations
  • Success Case Studies & Evolving Business Models
  • Collaboration and M&A Support
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • What novel combination therapies innovations will disrupt Oncology?
  • How are companies leveraging rare disease product development ?
  • What are advancements in digitization for R&D teams?
  • What are different drug repurposing routes companies opting?
  • What are innovations in personalized medicine mean with in allergy therapy area?
  • What areas to focus on during the product design stage to address any future regulatory concerns?
  • How are companies scanning Early innovation from academia?
  • Where are the innovation hot spots for enhancing patient experience?
  • Which start-ups can help me digitally transform drug dispensing experience?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Clinical trial analytics and continuous monitoring
  • Competitive intelligence, assessment & benchmarking
  • Partner identification, selection and prioritization
  • Unmet need identification and new opportunity area
  • Trends, events & impact monitoring
  • Portfolio synergy building & matchmaking
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • How can I select most appropriate partner/acquisition?
  • What future portfolio needs will I have with changing patient dynamics?
  • How can I introduce new technology related to remote patient monitoring?
  • What are the upcoming solutions to predict clinical outcomes?
  • Which smartphone apps can enhance my existing portfolio?
  • What are strategies and productivity benchmarks of US based large size companies for “virtual clinical trials”?
  • How patient centric clinical trials and R&D would shape up in long term with EPR development ?
  • What are the KOLs perspective on adoption and safety of digital pill?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Current and evolving patient journey
  • Comparison and landscape of clinical guidelines (Multiple countries)
  • Clinical outcome comparisons – Medicine/ Procedures/ Diagnosis
  • Digitalization and disease advocacy impact
  • Novel solution and innovation scouting
  • External innovation – Technology acquisition
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Which New digital technologies such as patient education and advocacy will
  • Where can I find new start-ups that can enable faster feedback loop?
  • How has Biomarker innovation disrupted prescription uptake ?
  • How supply chain disruptions are impacting the delivery of medical devices/technology?
  • Where will unmet needs be within medical affairs?
  • What are the key patient trends? Impact on my business?
  • How do I continuously track the start up innovation ecosystem in Pain segment ?
  • What technologies could be adopted from adjacent industries ?
  • How will regulations & reimbursement policies impact my market potential in the next 5years?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Portfolio gap analysis & Geography market focus
  • Health technology assessment, medical affairs and source of business
  • Entry/Exit/Licensing (Geography/Markets/Therapies)
  • Market sizing - short & long term forecasting, event impact analysis
  • Regulatory & reimbursement scenario planning
  • New Entity/Product Acquisition
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • What is the impact of sustainability on our business?
  • How regulations vary per region / country and how do they impact us?
  • Which are best-fit carbon capture technologies?
  • What are the winning circular business models?
  • How various bio-waste can be upcycled to be used in F&B, Pharma, HPC, etc. industries?
  • Which chemical recycling technologies are likely to win?
  • How do we continue to be a sustainability leader?
  • What is the future of plant / mill / refinery / shop floor / etc.?
  • What new features / designs / materials should be there in the product of the future?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Sustainability Roadmap
  • Peer Strategy and Best Practices
  • Solution / Technology / Partner etc. Scouting
  • Policy Drivers and Regulations Assessment
  • Future of process / product
  • LCA, Materiality, etc. assessment
  • New Use Cases & Business Models
  • Innovation Pipeline Development
  • Partner / Supplier Collaboration & M&A Support
  • Short Term
  • Medium Term
  • Long Term

Client's Success Stories

Digital Solutions for Orthopedic Surgeries

Medical Device & DiagnosticsMinimally Invasive Surgery (MIS)

Quick overview Our client was working towards digitalizing the various aspects related to patient management for orthopedic...

Indication Prioritization and Opportunity Selection

Life Sciences

Quick overview Our client needed support for the identification and selection of opportunities to grow and optimize its...

livestorm

You have Successfully Subscribed!

New Feature

Login with your mobile number. Update now.